Clinical Trial Update: Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin [NA]

View source ↗

Summary

Completed clinical trial analyzing chronic neuropathic pain markers in patients treated with oxaliplatin for digestive cancer and gynecologic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive Cancer
• Gynecologic Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Digestive Cancer, Gynecological Cancer | NA | Status: COMPLETED